9月30日 - ** 软件公司UiPath PATH.N宣布与英伟达NVDA.O和OpenAI合作，股价上涨14.6%至14.40美元。
** 盘初股价最高上涨约21
** PATH与NVDA合作 (link)，通过整合欺诈检测和医疗保健管理来提高企业自动化水平。
** 合作使用PATH的代理自动化服务和NVDA的Nemotron模型--一种旨在帮助计算机理解和生成类人内容的人工智能大脑。
** PATH还与OpenAI合作建立ChatGPT连接器，将OpenAI前沿模型集成到企业工作流程中。
** 包括本交易日的走势在内，PATH股价今年以来上涨了近18%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.